Pfizer Inc. v. Mylan Pharmaceuticals Inc.

• Court: Court of Appeals for the Federal Circuit
• Decided: January 13, 2016
• Docket: 15-1131
• Status: Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

PFIZER INC., PHARMACIA & UPJOHN COMPANY, PHARMACIA & UPJOHN COMPANY LLC, SUGEN, INC., C.P. PHARMACEUTICALS INTERNATIONAL C.V., PFIZER PHARMACEUTICALS LLC, PF PRISM C.V., Plaintiffs-Appellees

v.

MYLAN PHARMACEUTICALS INC., Defendant-Appellant ______________________

2015-1131 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:10-cv-00528-GMS, Judge Gregory M. Sleet. ______________________

JUDGMENT ______________________

THOMAS H.L. SELBY, Williams & Connolly LLP, Wash- ington, DC, argued for plaintiffs-appellees. Also repre- sented by STANLEY E. FISHER, JESSAMYN SHELI BERNIKER, SARA KAISER CREIGHTON. DOUGLAS H. CARSTEN, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA, argued for defendant- appellant. Also represented by PETER SOO KANG; KATHERINE HASPER, Palo Alto, CA; ROBERT DELAFIELD, Austin, TX. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (DYK, WALLACH, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 13, 2016 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court